Sixfold Bioscience
Delivering RNA therapies.
London, United Kingdom · Founded 2018 · $10.5M raised
- Headquarters
- London
- Employees
- 11–50
- Founded
- 2018
- Website
- sixfold.bio
- Total Funding
- $10.5M
- Last Round
- $10.5M SeedDec 2021
- Rounds
- 1
About
Sixfold is focused on the commercialisation of its patented drug delivery systems for RNA therapeutics such as siRNAs for gene silencing and mRNAs for gene expression.
Summary
Sixfold Bioscience is a Biotech company based in London, United Kingdom, founded in 2018. It has raised $10.5M in total across 1 round, most recently a $10.5M Seed round in Dec 2021. Investors include Cantos, Lombard Street Ventures and Pi Campus.
Tech & App Stack
2 technologies & apps tracked
Create a free account — 10 credits a month to unlock the full tech & app stack, funding history, and valuations.
Sign up to view the funding chart
Create a free account — you'll get 10 credits a month to unlock funding history, valuations, and tech stacks.
Funding History
Dec 2021
Investors
Similar Companies

China's leading mRNA biotech company developing therapeutics for cancer and infectious diseases.

Asymchem provides R&D and one-stop production services to the world's top pharmaceutical companies.
Developer of engineered cells as medicines to treat diseases by repairing or replacing cells for ...

Late-stage biopharma using single-molecule tracking, AI, and engineering to discover and develop ...
Biopharmaceutical company developing and commercializing RNAi therapeutics to treat genetically d...
Clinical-stage programmable cell therapy company developing engineered T-cell therapies for solid...

